TNF and neoplasm: Whilst we have not investigated the immunotherapeutic potential of TNFα‐CSG, our findings suggest that TNFα‐CSG may be used to inflame tumours which lack intrinsic effector T cells, and its full therapeutic potential could be achieved in combination with immune checkpoint blockade or other immunotherapeutic strategies.